Click HERE to download the PDF version

SK BIOTEK IS A CONTRACT DEVELOPMENT MANUFACTURING ORGANISATION (CDMO) KNOWN FOR ITS PRESENCE IN CUSTOM CHEMICAL DEVELOPMENT, ADVANCED INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING. COULD YOU TALK ABOUT THE KEY MILESTONES WHICH BROUGHT SK BIOTEK TO ITS CURRENT LEVEL OF SUCCESS?

SK biotek (SKBT) is part of a large Korean conglomerate, SK holdings, with approximately $100 billion in annual sales.

SKBT has been in existence since 1996 and had grown organically during the early years to incorporate a development and manufacturing site in Daejon, Korea and more recently a second facility in Korea, in Sejong, with combined capacity of 320m³.  The key technology differentiation is in the area of continuous flow and SK ...